LYTIR

Insider · SEC Form 4 · 10% Owner

5AM Ventures V, L.P.

In the 12 months to Nov 8, 2026, on the open market: sold $1.2M of TRDA. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.2M in total.Jul: Insider sales $807KAug: Insider sales $432KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. TRDASold: Entrada Therapeutics, Inc. Aug 7, 2026 52,317 shares filed Aug 10, 2026 2,783,781 shares held directly after, as filed filing $358K
  2. TRDASold: Entrada Therapeutics, Inc. Aug 6, 2026 10,494 shares filed Aug 10, 2026 2,836,098 shares held directly after, as filed filing $73K
  3. TRDASold: Entrada Therapeutics, Inc. Jul 31, 2026 1,718 shares filed Aug 3, 2026 2,846,592 shares held directly after, as filed filing $12K
  4. TRDASold: Entrada Therapeutics, Inc. Jul 30, 2026 114,756 shares filed Aug 3, 2026 2,848,310 shares held directly after, as filed filing $795K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.